Placebo-Controlled
Showing 26 - 50 of >10,000
Chronic Inducible Urticaria Trial (Remibrutinib, Placebo)
Not yet recruiting
- Chronic Inducible Urticaria
- Remibrutinib
- Placebo
- (no location specified)
Jul 28, 2023
Healthy Volunteer Trial in Wuhan (GFH312 100 mg, GFH312 200 mg, GFH312 120mg)
Completed
- Healthy Volunteer
- GFH312 100 mg
- +3 more
-
Wuhan, Hubei, ChinaUnion Hospital, Tongji Medical College, Huazhong University of S
Aug 6, 2023
Recurrent Aphthous Ulcer Trial in Rome (OR-AT0222, Placebo)
Recruiting
- Recurrent Aphthous Ulcer
- OR-AT0222
- Placebo
-
Rome, ItalyPoliclinico "Umberto I" - U.O.C. di Odontoiatria Pediatrica ed O
Jul 17, 2023
Skin Ageing Trial in Villeurbanne (soy isoflavones, Placebo)
Not yet recruiting
- Skin Ageing
- soy isoflavones
- Placebo
-
Villeurbanne, FranceEurofins Dermscan Pharmascan
Sep 14, 2023
Rheumatoid Arthritis Trial (SBD121, Placebo)
Not yet recruiting
- Rheumatoid Arthritis
- SBD121
- Placebo
- (no location specified)
Aug 16, 2023
Neurofibromatosis Type 1, Plexiform Neurofibromas, Post-operative Trial in Beijing, Shanghai (Selumetinib, Placebo)
Not yet recruiting
- Neurofibromatosis Type 1
- +2 more
- Selumetinib
- Placebo
-
Beijing, China
- +2 more
Apr 11, 2023
Allergic Rhinitis Due to Grass Pollen Trial in Lund, Stockholm, Örebro (SLIT Grazax ALK Nordic 75 000 SQ-T, ILIT + Vitamin D,
Recruiting
- Allergic Rhinitis Due to Grass Pollen
- SLIT Grazax ALK Nordic 75 000 SQ-T
- +2 more
-
Lund, Sweden
- +2 more
Sep 25, 2023
PCOS, Vitamin D Trial in Dhaka (Vitamin D3, Placebo Oral Tablet)
Recruiting
- PCOS
- Vitamin D
- Vitamin D3
- Placebo Oral Tablet
-
Dhaka, BangladeshBSMMU
Oct 29, 2023
Healthy Volunteers Trial in Saint Paul (Recombinant human plasma gelsolin, )
Recruiting
- Healthy Volunteers
- Recombinant human plasma gelsolin
- placebo
-
Saint Paul, MinnesotaNucleus Network
Mar 16, 2023
Neonatal Jaundice, Microtia, Pregnancy Related Trial (Vivomixx®, Placebo)
Not yet recruiting
- Neonatal Jaundice
- +2 more
- Vivomixx®
- Placebo
- (no location specified)
Oct 17, 2023
Asthma Trial (XKH001 Injection, XKH001 Placebo Injection)
Not yet recruiting
- Asthma
- XKH001 Injection
- XKH001 Placebo Injection
- (no location specified)
Aug 13, 2023
Drug-Induced Liver Injury, Cholestatic Liver Injury, Mixed Liver Injury Trial in Shanghai (MT2004 Capsule, MT2004 Capsule
Recruiting
- Drug-Induced Liver Injury
- +2 more
- MT2004 Capsule
- MT2004 Capsule Placebo
-
Shanghai, Shanghai, ChinaShanghai Jiaotong University School of Medicine,Renji Hospital
Aug 25, 2023
Influenza Trial (Multistrain probiotic, Placebo)
Not yet recruiting
- Influenza
- Multistrain probiotic
- Placebo
- (no location specified)
Oct 26, 2023
Axial Spondyloarthritis Trial (Tofacitinib 5 MG)
Not yet recruiting
- Axial Spondyloarthritis
- Tofacitinib 5 MG
- (no location specified)
Oct 29, 2023
Photoaging Trial (Astaxanthin 6 mg daily, Placebo)
Not yet recruiting
- Photoaging
- Astaxanthin 6 mg daily
- Placebo
- (no location specified)
May 31, 2023
MDD Trial (NMRA-335140, Placebo)
Not yet recruiting
- Major Depressive Disorder
- NMRA-335140
- Placebo
- (no location specified)
Sep 21, 2023
Pain, Acute Pain Trial in Overland Park (SBS-1000, Placebo)
Recruiting
- Pain
- Acute Pain
- SBS-1000
- Placebo
-
Overland Park, KansasAltasciences Clinical Kansas
Jan 31, 2023
MDD Trial (NMRA 335140, Placebo)
Not yet recruiting
- Major Depressive Disorder
- NMRA 335140
- Placebo
- (no location specified)
Sep 1, 2023
Hereditary Sensory Neuropathy Type I Trial in London (L-serine, Placebo)
Recruiting
- Hereditary Sensory Neuropathy Type I
- L-serine
- Placebo
-
London, United KingdomUniversity College London
Oct 31, 2023
Cough Trial in Jinan (HS-10383, HS-10383 Placebo)
Recruiting
- Cough
- HS-10383
- HS-10383 Placebo
-
Jinan, Shandong, ChinaShandong provincial qianfoshan hospital
Oct 19, 2023